Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Davis

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical Kidney Journal|September 29, 2015
Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physiciansAnna Baker, Dominic King, James Marsh, et al.
Experimental Hematology & Oncology|February 21, 2013
The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysisStuart Mealing, Leticia Barcena, Neil Hawkins, et al.
Health Promotion Practice|September 11, 2004
CHWs get credit: a 10-year history of the first college-credit certificate for community health workers in the United StatesMary Beth Love, Vicki Legion, Janet K Shim, et al.
Current Medical Research and Opinion|December 16, 2011
Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemiaMarianne Ulcickas Yood, Susan A Oliveria, Mark Cziraky, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Patient Preferences for Chronic Myeloid Leukemia Medication Regimen Attributes and their Potential Impact on Adherence: Results from a Multi-national Conjoint StudyIshan Hirji, Jessica Grinspan, Emuella Flood, et al.
Future Oncology (London, England)|March 28, 2023
Neoadjuvant treatment and survival outcomes by pathologic complete response in HER2-negative early breast cancersAmanda Crosbie, Trong Kim Le, Ying Zhang, et al.
Journal of Clinical Immunology|March 7, 2007
Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndromeRita Kansal, Catherine Davis, Melanie Hansmann, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 9, 2025
Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 649: 4-year follow-up resultsDaniel Lin, Wenying Quan, Marne Garretson, et al.
Child Abuse & Neglect|November 13, 2019
Identifying compassion satisfaction, burnout, & traumatic stress in Children's Advocacy CentersMegan M Letson, Catherine Davis, Jennifer Sherfield, et al.
Annals of Hematology|September 5, 2018
Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 studyDavid Cella, Jan McKendrick, Amber Kudlac, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical Kidney Journal|September 29, 2015
Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physiciansAnna Baker, Dominic King, James Marsh, et al.
Experimental Hematology & Oncology|February 21, 2013
The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysisStuart Mealing, Leticia Barcena, Neil Hawkins, et al.
Health Promotion Practice|September 11, 2004
CHWs get credit: a 10-year history of the first college-credit certificate for community health workers in the United StatesMary Beth Love, Vicki Legion, Janet K Shim, et al.
Current Medical Research and Opinion|December 16, 2011
Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemiaMarianne Ulcickas Yood, Susan A Oliveria, Mark Cziraky, et al.
Journal of Health Economics and Outcomes Research|September 4, 2023
Patient Preferences for Chronic Myeloid Leukemia Medication Regimen Attributes and their Potential Impact on Adherence: Results from a Multi-national Conjoint StudyIshan Hirji, Jessica Grinspan, Emuella Flood, et al.
Future Oncology (London, England)|March 28, 2023
Neoadjuvant treatment and survival outcomes by pathologic complete response in HER2-negative early breast cancersAmanda Crosbie, Trong Kim Le, Ying Zhang, et al.
Journal of Clinical Immunology|March 7, 2007
Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndromeRita Kansal, Catherine Davis, Melanie Hansmann, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 9, 2025
Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 649: 4-year follow-up resultsDaniel Lin, Wenying Quan, Marne Garretson, et al.
Child Abuse & Neglect|November 13, 2019
Identifying compassion satisfaction, burnout, & traumatic stress in Children's Advocacy CentersMegan M Letson, Catherine Davis, Jennifer Sherfield, et al.
Annals of Hematology|September 5, 2018
Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 studyDavid Cella, Jan McKendrick, Amber Kudlac, et al.
Pageof 4